Introduction to the Five Most Prevalent Cancers | Reference Price¥1710
-
lung cancerThe incidence and mortality rates of lung cancer in China are the highest among the incidence and deaths of malignant tumors in China. The overall 5-year survival rate is 29.6%. Among them, the 5-year survival rate of early-stage patients can reach 92%, intermediate-stage patients is 29.6%, and the rate drops to 9.8% for advanced-stage patients.
-
gastric cancerChina is one of the countries in the world with a high incidence and mortality rate of gastric cancer . The overall 5-year survival rate is 41.1%.The 5-year survival rate for patients with early gastric cancer is 80.1%, intermediate stage is 41%, and advanced stage is 7.1%.
-
liver cancerThe incidence and mortality rates of liver cancer in China account for the third largest number of malignant tumors. The overall 5-year survival rate is 21.5%. The 5-year survival rate for patients with early-stage hepatocellular carcinoma is 80%, intermediate-stage is 22.5%, and advanced-stage is 4.4%.
-
esophageal cancerEsophageal cancer is a common malignant tumor of the digestive system in China, and China is in the high incidence of esophageal cancer in the world. The overall 5-year survival rate is 23.3%. The 5-year survival rate for patients with early esophageal cancer is 90%, intermediate stage is 27.9%, and advanced stage is 15%.
-
colorectal cancerThe population-standardized incidence of colorectal cancer in our country is characterized by a higher incidence in men than in women. The overall 5-year survival rate was 65.81 TP3T. 5-year survival rates were 91.81 TP3T for early-stage patients, 65.81 TP3T for intermediate-stage, and 17.11 TP3T for advanced-stage.
General information
-
Stronger technical endorsement
Tumor early screening technology from Mayo Hospital and Hefei Institute of Materials Science, Chinese Academy of Sciences, represents the international leading level.
-
More complete solutions
The whole experimental process and the reagents involved, including sampling tubes, primer design, extraction, transformation, desulfonation, on-line amplification are all developed by independent research, which is a complete set of detection system, and the whole process can be traced back to the highest degree of matching, which can best guarantee the quality of detection.
-
Higher accuracy
All of them adopt the most advanced tumor DNA methylation detection technology that is internationally recognized and can be used for clinical use in the field of early cancer screening at this stage, which has been written into the consensus of many experts and diagnostic and therapeutic guidelines, and its detection sensitivity and specificity are much higher than those of traditional tumor markers, with the advantages of being earlier, more non-invasive and more accurate.

